152 related articles for article (PubMed ID: 10408568)
1. Multiple cerebral infarctions associated with ovarian hyperstimulation syndrome.
Yoshii F; Ooki N; Shinohara Y; Uehara K; Mochimaru F
Neurology; 1999 Jul; 53(1):225-7. PubMed ID: 10408568
[TBL] [Abstract][Full Text] [Related]
2. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
[TBL] [Abstract][Full Text] [Related]
3. [Multiple organ failure syndrome after ovarian hyperstimulation].
Diatta B; Petrognani R; Angel G; Marquine C; Eliet J; Seck M; Seignot P
Med Trop (Mars); 1997; 57(4):373-4. PubMed ID: 9612780
[TBL] [Abstract][Full Text] [Related]
4. Acute cerebrovascular accidents with severe ovarian hyperstimulation syndrome.
El Sadek MM; Amer MK; Fahmy M
Hum Reprod; 1998 Jul; 13(7):1793-5. PubMed ID: 9740425
[TBL] [Abstract][Full Text] [Related]
5. Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome.
Inbar OJ; Levran D; Mashiach S; Dor J
Fertil Steril; 1994 Nov; 62(5):1075-6. PubMed ID: 7926122
[TBL] [Abstract][Full Text] [Related]
6. Middle cerebral artery thrombosis after IVF and ovarian hyperstimulation: a case report.
Jing Z; Yanping L
Fertil Steril; 2011 Jun; 95(7):2435.e13-5. PubMed ID: 21601668
[TBL] [Abstract][Full Text] [Related]
7. Ovarian hyperstimulation syndrome associated with clomiphene citrate.
Mitchell SY; Fletcher HM; Williams E
West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032
[TBL] [Abstract][Full Text] [Related]
8. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
[TBL] [Abstract][Full Text] [Related]
9. Ischemic stroke in a young woman with ovarian hyperstimulation syndrome.
Hwang WJ; Lai ML; Hsu CC; Hou NT
J Formos Med Assoc; 1998 Jul; 97(7):503-6. PubMed ID: 9700249
[TBL] [Abstract][Full Text] [Related]
10. Severe ovarian hyperstimulation syndrome despite low plasma oestrogen concentrations in a hypogonadotrophic, hypogonadal patient.
Levy T; Orvieto R; Homburg R; Peleg D; Dekel A; Ben-Rafael Z
Hum Reprod; 1996 Jun; 11(6):1177-9. PubMed ID: 8671418
[TBL] [Abstract][Full Text] [Related]
11. Long hospitalization for severe ovarian hyperstimulation syndrome with persistent right hydrothorax and two occurrences of pneumonia.
Lin J; Li X; Zhang L
Int J Gynaecol Obstet; 2017 Mar; 136(3):350-352. PubMed ID: 28099716
[No Abstract] [Full Text] [Related]
12. Severe ovarian hyperstimulation syndrome (OHSS) and icterus.
Nawroth F; Heinrich J; Bruns U; Wood WG
Hum Reprod; 1996 Nov; 11(11):2441-2. PubMed ID: 8981129
[TBL] [Abstract][Full Text] [Related]
13. GnRH agonist trigger with intensive luteal phase support vs. human chorionic gonadotropin trigger in high responders: an observational study reporting pregnancy outcomes and incidence of ovarian hyperstimulation syndrome.
Christopoulos G; Vlismas A; Carby A; Lavery S; Trew G
Hum Fertil (Camb); 2016 Sep; 19(3):199-206. PubMed ID: 27662416
[TBL] [Abstract][Full Text] [Related]
14. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
[TBL] [Abstract][Full Text] [Related]
15. Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.
Sousa M; Cunha M; Teixeira da Silva J; Oliveira C; Silva J; Viana P; Barros A
Reprod Biol Endocrinol; 2015 Jun; 13():66. PubMed ID: 26100393
[TBL] [Abstract][Full Text] [Related]
16. Acute oligo-anuria during ovarian hyperstimulation syndrome.
Demey HE; Daelemans R; Galdermans D; Verpooten GA; De Broe ME; Bossaert LL
Acta Obstet Gynecol Scand; 1987; 66(8):741-3. PubMed ID: 3129900
[TBL] [Abstract][Full Text] [Related]
17. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
18. Correct timing of administration of diuretic agents for the treatment of ovarian hyperstimulation syndrome.
Bar-Hava I; Homburg R
Gynecol Endocrinol; 1993 Mar; 7(1):63-5. PubMed ID: 8506765
[No Abstract] [Full Text] [Related]
19. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone.
Weissman A; Barash A; Shapiro H; Casper RF
Hum Reprod; 1998 Dec; 13(12):3421-4. PubMed ID: 9886527
[TBL] [Abstract][Full Text] [Related]
20. Agonist trigger: what is the best approach? Agonist trigger and low dose hCG.
Humaidan P
Fertil Steril; 2012 Mar; 97(3):529-30. PubMed ID: 22154368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
